Stratec SE stock (DE000STRA555): Xetra trade holds near EUR 26.95

Stratec SE traded at EUR 26.95 on Xetra on 06/02/2026, with the German listing still active and the company identified on the domestic market as STRA55/SBS.

Stratec SE shares were quoted at EUR 26.95 on Xetra on 06/02/2026, according to a realtime market page that identifies the stock as STRATEC SE with WKN STRA55 and ticker SBS.

In Germany, that keeps the stock anchored to its home market on Xetra, where investors track the domestic quote in euros and the company remains listed under its German market identifiers.

As of: 06/02/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: Stratec
• Sector/industry: Medical technology and laboratory automation
• Headquarters/country: Birkenfeld, Germany
• Core markets: Europe, North America, and selected international healthcare markets
• Key revenue drivers: Instrument systems, consumables, and service related to automated diagnostic workflow solutions
• Home exchange/listing venue: Xetra (SBS)
• Trading currency: EUR

Stratec SE: core business model

Stratec designs and supplies automation systems and related components for laboratory and diagnostic workflows, with revenue tied to instrument placements, recurring consumables, and service activity.

Latest quarterly results for Stratec SE at a glance

No verified quarterly filing or company earnings release was available in the provided search results, so the Tuesday module cannot be populated with dated figures without risking unsupported claims.

That means today's article is led by the verified German-market price data rather than by a fresh earnings update, while the home-country frame remains intact through the Xetra quote and German identifiers.

Stratec is best understood as a German diagnostics-enablement business whose sales mix is typically linked to installed systems and the downstream use of those systems in routine laboratory work.

Conclusion

Stratec's latest verified datapoint in this run is the Xetra quote at EUR 26.95 on 06/02/2026, which keeps the story rooted in Germany's home market.

Without a fresh earnings release in the search results, the most relevant context is the stock's domestic listing status and its diagnostics automation business model, both of which remain central to how the market reads the name.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.